Published by Coherent Market Insights
Posted on September 14, 2021
CMI published a business research report on “Deep Brain Stimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021–2026”. Deep Brain Stimulation Devices with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Deep Brain Stimulation Devices Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Deep Brain Stimulation Devices Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Get Your Sample Copy of the Deep Brain Stimulation Devices Market Report 2021
Deep Brain Stimulation Devices Market- Insights
A deep brain stimulation (DBS) device, also known as brain pacemaker, helps to decrease the symptoms of neurological disorders such as the Parkinson’s disease (PD). One of the three U.S. Food and Drug Administration (FDA) approved brain sites can be used to implant a DBS device to block the electrical signals from these sites to the brain. These sites include the ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is used in the treatment of patients suffering from PD for at least four years and are on medications albeit with motor complications.
There are several other surgical options such as Thalamotomy and Pallidotomy. However, the high preference for DBS is attributed to its reversible approach and no need for destruction of tissue.
Increasing approval and launch of novel devices is expected to boost growth of the global deep brain stimulation devices market
Increasing focus of major market players towards development and launch of novel DBS devices is expecte to propel the market growth. For instance, in January 2019, Boston Scientific Corporation launched two new DBS devices namely the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) systems. Similarly, in June 2015, the U.S. Food and Drug Administration (FDA) approved St. Jude Medical’s Brio Neurostimulation System, a DBS device that helps to reduce symptoms of PD and essential tremors. Therefore, increasing launch and approval of such novel devices is expected to boost growth of the global deep brain stimulation devices market over the forecast period.
Major market players are also focused on launching upgraded versions of their already approved DBS devices in the market. For instance, in August 2018, Abbott Laboratories received the U.S. FDA approval for an over-the-air software upgrade for all currently implanted Infinity DBS systems that deliver magnetic resonance (MR)-conditional labeling. Therefore, approval and launch of such upgraded DBS devices is expected to create conducive environment for the market growth over the forecast period.
The global deep brain stimulation devices market size was valued at US$ 831.6 Mn in 2018, and is expected to exhibit a CAGR of 9.7% over the forecast period (2020 – 2027).
Reasons to Purchase this Report
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/84
High prevalence of diseases such as Parkinson’s disease and epilepsy is expected to fuel the global deep brain stimulation devices market growth
Increasing prevalence of PD is expected to boost demand for DBS devices. For instance, according to the Parkinson’s Disease Foundation, as of 2016, over 10 million people are suffering from Parkinson’s disease, worldwide. The findings published by the organization demonstrated that incidence rate of PD increases with age and only 4% of people were diagnosed with PD before the age of 50 years. According to the same source, in 2017, the incidence rate of PD in the U.S is as high as 60,000, annually.
Moreover, according to Parkinson’s Australia Inc. around 11,544 new cases of PD were diagnosed in Australia in 2014. According to the statistics released by Parkinson Canada, the number of people suffering from PD in Canada is expected to reach over 163,700 by 2031 (double than the prevalence in 2011).
Increasing prevalence of epilepsy is also expected to boost demand for DBS devices. For instance, according to the data published by the Centers for Disease Control and Prevention, in 2015, around 1.2% of the U.S. population suffered from active epilepsy, which was around 3.4 million people and included 3 million adults and 470,000 children.
Therefore, high prevalence of PD and epilepsy worldwide is expected to drive the global deep brain stimulation devices market growth over the forecast period.
View Press Release For More Information
Key players operating in the global deep brain stimulation devices market include, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA.
Main points in Deep Brain Stimulation Devices Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Deep Brain Stimulation Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Deep Brain Stimulation Devices Industry Impact
Chapter 2 Global Deep Brain Stimulation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Deep Brain Stimulation Devices (Volume and Value) by Type
2.3 Global Deep Brain Stimulation Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Deep Brain Stimulation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Deep Brain Stimulation Devices Market Analysis
Chapter 6 East Asia Deep Brain Stimulation Devices Market Analysis
Chapter 7 Europe Deep Brain Stimulation Devices Market Analysis
Chapter 8 South Asia Deep Brain Stimulation Devices Market Analysis
Chapter 9 Southeast Asia Deep Brain Stimulation Devices Market Analysis
Chapter 10 Middle East Deep Brain Stimulation Devices Market Analysis
Chapter 11 Africa Deep Brain Stimulation Devices Market Analysis
Chapter 12 Oceania Deep Brain Stimulation Devices Market Analysis
Chapter 13 South America Deep Brain Stimulation Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Deep Brain Stimulation Devices Business
Chapter 15 Global Deep Brain Stimulation Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Deep Brain Stimulation Devices Market will grow at 9.7% CAGR, to be valued at US$ 1898.4 Mn by 2027 | Global Industry Analysis by Company Profiles, Segments, Size, Landscape and Demand appeared first on Gatorledger.
CMI published a business research report on “Deep Brain Stimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021–2026”. Deep Brain Stimulation Devices with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Deep Brain Stimulation Devices Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Deep Brain Stimulation Devices Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Get Your Sample Copy of the Deep Brain Stimulation Devices Market Report 2021
Deep Brain Stimulation Devices Market- Insights
A deep brain stimulation (DBS) device, also known as brain pacemaker, helps to decrease the symptoms of neurological disorders such as the Parkinson’s disease (PD). One of the three U.S. Food and Drug Administration (FDA) approved brain sites can be used to implant a DBS device to block the electrical signals from these sites to the brain. These sites include the ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is used in the treatment of patients suffering from PD for at least four years and are on medications albeit with motor complications.
There are several other surgical options such as Thalamotomy and Pallidotomy. However, the high preference for DBS is attributed to its reversible approach and no need for destruction of tissue.
Increasing approval and launch of novel devices is expected to boost growth of the global deep brain stimulation devices market
Increasing focus of major market players towards development and launch of novel DBS devices is expecte to propel the market growth. For instance, in January 2019, Boston Scientific Corporation launched two new DBS devices namely the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) systems. Similarly, in June 2015, the U.S. Food and Drug Administration (FDA) approved St. Jude Medical’s Brio Neurostimulation System, a DBS device that helps to reduce symptoms of PD and essential tremors. Therefore, increasing launch and approval of such novel devices is expected to boost growth of the global deep brain stimulation devices market over the forecast period.
Major market players are also focused on launching upgraded versions of their already approved DBS devices in the market. For instance, in August 2018, Abbott Laboratories received the U.S. FDA approval for an over-the-air software upgrade for all currently implanted Infinity DBS systems that deliver magnetic resonance (MR)-conditional labeling. Therefore, approval and launch of such upgraded DBS devices is expected to create conducive environment for the market growth over the forecast period.
The global deep brain stimulation devices market size was valued at US$ 831.6 Mn in 2018, and is expected to exhibit a CAGR of 9.7% over the forecast period (2020 – 2027).
Reasons to Purchase this Report
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/84
High prevalence of diseases such as Parkinson’s disease and epilepsy is expected to fuel the global deep brain stimulation devices market growth
Increasing prevalence of PD is expected to boost demand for DBS devices. For instance, according to the Parkinson’s Disease Foundation, as of 2016, over 10 million people are suffering from Parkinson’s disease, worldwide. The findings published by the organization demonstrated that incidence rate of PD increases with age and only 4% of people were diagnosed with PD before the age of 50 years. According to the same source, in 2017, the incidence rate of PD in the U.S is as high as 60,000, annually.
Moreover, according to Parkinson’s Australia Inc. around 11,544 new cases of PD were diagnosed in Australia in 2014. According to the statistics released by Parkinson Canada, the number of people suffering from PD in Canada is expected to reach over 163,700 by 2031 (double than the prevalence in 2011).
Increasing prevalence of epilepsy is also expected to boost demand for DBS devices. For instance, according to the data published by the Centers for Disease Control and Prevention, in 2015, around 1.2% of the U.S. population suffered from active epilepsy, which was around 3.4 million people and included 3 million adults and 470,000 children.
Therefore, high prevalence of PD and epilepsy worldwide is expected to drive the global deep brain stimulation devices market growth over the forecast period.
View Press Release For More Information
Key players operating in the global deep brain stimulation devices market include, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA.
Main points in Deep Brain Stimulation Devices Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Deep Brain Stimulation Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Deep Brain Stimulation Devices Industry Impact
Chapter 2 Global Deep Brain Stimulation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Deep Brain Stimulation Devices (Volume and Value) by Type
2.3 Global Deep Brain Stimulation Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Deep Brain Stimulation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Deep Brain Stimulation Devices Market Analysis
Chapter 6 East Asia Deep Brain Stimulation Devices Market Analysis
Chapter 7 Europe Deep Brain Stimulation Devices Market Analysis
Chapter 8 South Asia Deep Brain Stimulation Devices Market Analysis
Chapter 9 Southeast Asia Deep Brain Stimulation Devices Market Analysis
Chapter 10 Middle East Deep Brain Stimulation Devices Market Analysis
Chapter 11 Africa Deep Brain Stimulation Devices Market Analysis
Chapter 12 Oceania Deep Brain Stimulation Devices Market Analysis
Chapter 13 South America Deep Brain Stimulation Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Deep Brain Stimulation Devices Business
Chapter 15 Global Deep Brain Stimulation Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Deep Brain Stimulation Devices Market will grow at 9.7% CAGR, to be valued at US$ 1898.4 Mn by 2027 | Global Industry Analysis by Company Profiles, Segments, Size, Landscape and Demand appeared first on Gatorledger.
Explore more articles in the Research Reports category
